Literature DB >> 30560922

Images of subclinical atherosclerosis incentivize cardiovascular risk reduction.

Gregory B Lim1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30560922     DOI： 10.1038/s41569-018-0150-5

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial.

Authors:  Ulf Näslund; Nawi Ng; Anna Lundgren; Eva Fhärm; Christer Grönlund; Helene Johansson; Bernt Lindahl; Bertil Lindahl; Kristina Lindvall; Stefan K Nilsson; Maria Nordin; Steven Nordin; Emma Nyman; Joacim Rocklöv; Davide Vanoli; Lars Weinehall; Patrik Wennberg; Per Wester; Margareta Norberg
Journal:  Lancet       Date:  2018-12-03       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.